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Abstract 22 
Aim: Pain is increasingly recognised as an important symptom to be addressed as part of 23 
clinical care in people with cerebral palsy (CP). We explore factors associated with pain and 24 
pain severity in a cross-sectional study of a population cohort of young people (YP) with 25 
bilateral CP and compare parent/carer (PC) and YP self report. 26 
Method: Of the 278 survivors aged 13-19 years from the South Thames region, SH&PE 27 
cohort, of 338 YP with bilateral CP, 212 PC and 153 YP completed questionnaires on the 28 
presence, severity, timing, site, associated factors, impact and treatment of pain.  29 
Results: Seventy percent of PCs reported pain occurring in the last three months, 59% 30 
within the last week and 50% within the last day associated with severity of motor 31 
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impairment and ambulant/ non- ambulant and ‘regularly experienced’ by 56%. Of YP able to 1 
do so, 63% reported pain in the last three months, 50% the last week and 42% the last day, 2 
with 48% reporting regular pain. There was strong agreement between PC and YP reporting 3 
of pain and its severity over the last 3 months. Pain severity was associated with severity of 4 
motor impairment, health problems, particularly constipation, spasticity, greater equipment 5 
use and higher emotional score but not gender, intellectual disability, speech level or 6 
maternal education. Sites of pain were arm, leg, back, chest and hips, multiple in two-thirds. 7 
Pain in individuals with less severe motor impairment was associated with voluntary 8 
movement and with being moved in those with a severe motor impairment.   Greater pain 9 
severity at all time periods had a negative impact on PC and YP measures of quality of life in 10 
both physical and psychological well-being.   11 
Interpretation Increasing awareness of the co-morbidities in CP, particularly general health 12 
and constipation, may help more effectively treat and thereby reduce the high levels of pain 13 
experienced by young people with cerebral palsy 14 
Word count Abstract 305 15 
Word count 4034 16 
What this study adds 17 
 Regular moderate or severe pain is reported in YP with bilateral CP at all levels of 18 
GMFCS but more frequently in YP who are non-ambulant compared with ambulant. 19 
 General ill health and particularly constipation is strongly associated with severity of 20 
pain after controlling for severity of CP. 21 
 Pain occurs most often in ambulant YP during voluntary activity and in YP who are 22 
non-ambulant when being moved. 23 
 There is strong agreement between PCs and YP about pain presence and severity. 24 
Introduction 25 
Cerebral palsy is usually thought of as a disorder of motor function but multiple co-26 
morbidities impact negatively on other body functions (NICE 2017)1. Pain has been 27 
increasingly recognised as both common and negatively affecting quality of life and both 28 
participation and ‘well-being’ for children and young people 2-6.  Prevalence rates of pain in 29 
young people with CP vary in recent studies from 27% to 77%. Such differences depend on 30 
a number of factors6-8: the age range (pain increases with age6 both in prevalence and 31 
intensity5,8,); gender (pain is reported more frequently in females6, increasingly so with age); 32 
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the population (whether population based cohorts3,4, a total population of CP 5,6, or clinical 1 
populations8) and whether non ambulant5, or non-verbal8 ;  the specified recall time (no time 2 
frame as in Westbon 37%7 or a time frame of the last week and  the last four weeks, 60% 3 
and 73% respectively3,4. Whether intensity of pain is reported is also relevant eg in 101 non-4 
verbal children and adolescents with CP aged 2 to 20 years parent/carers (PCs) reported 5 
pain in 65% during the last 4 weeks; pain was intense in 17%, and daily pain occurred in 6 
28%8. Pain experience may change over time as may intensity8.  Those who at a younger 7 
age have no pain may develop pain and those with more severe initial pain and higher gross 8 
motor function have lower pain at follow-up9. Also relevant to prevalence is who is reporting 9 
the pain: self-report or physician observer, 54% versus 39% respectively10.  Parent and self-10 
report, where both can contribute, have been found to be moderately correlated in 13-17 11 
year olds although parents tended to relatively overestimate their child’s pain if self-reported 12 
pain was infrequent or mild and underestimate it if self-reported pain was frequent or 13 
severe4.  14 
Factors associated with pain are severity of CP, distribution of CP (4 limb CP having more 15 
severe pain) and motor type (dystonia) in one study8 although not in Westbom et al7. 16 
Reports of pain are not associated with socioeconomic factors, including parental education 17 
in two large studies3,4,5.  Musculo-skeletal causes are assumed to be most common11,12,13  18 
but constipation is noted 8, 10 . Sites of pain are most commonly hips, knees and feet13. 19 
Greater levels of pain have been positively associated with emotional difficulties in YP 4 who 20 
experience both increased pain intensity and pain anxiety14.  Pain has been linked explicitly 21 
to therapy and clinical procedures4 such as stretching procedures15 (in the latter study 22 
parent/carers underreported pain compared with self and physio report).   23 
Systematic enquiry about pain from PCs and YP is now part of good clinical care in CP. 24 
Ascertaining pain in individuals who can self-report is relatively straightforward.  Ascertaining 25 
pain in the non-verbal population is more problematic as pain has to be inferred from 26 
behaviour and relies on parent/carer/observer report. High agreement was reported between 27 
physiotherapist and parents in non-verbal children9. Which pain questionnaire to use has 28 
varied across studies and a systematic review concluded that tools were often not validated 29 
in children with CP nor was there one tool to meet the needs of all children experiencing 30 
chronic pain 16. 31 
In a recent commentary in Developmental Medicine and Child Neurology Ramstad17 posed 32 
the question, “do we need another report on pain in cerebral palsy?” However clinically 33 
important questions remain. Pain is discussed in the literature as largely musculo-skeletal in 34 
origin. We predicted that other factors such as gastrointestinal dysmotility, especially 35 
constipation, were important and potentially amenable to treatment. Pain has also been 36 
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explicitly linked to therapeutic interventions which has important implications for all clinicians. 1 
We predicted that pain is linked to different times and activities in different groups and 2 
possibly to the use of orthoses and postural equipment. We wanted to assess whether PCs 3 
and YP were in agreement about presence, timing, site and severity of pain- a clinically 4 
important assumption for those who have limited communication.  We were interested in 5 
what treatments individuals use to control pain as Westbom found that in clinical practice, 6 
although structured assessments had captured the presence of pain, very little intervention 7 
was recorded in the notes of the YP7. The implications of pharmacological treatment in 8 
Chronic Pain in Cerebral Palsy was also highlighted in the recent review on pathophysiology 9 
by Blackman et al18. To address these questions we report the presence, severity, timing, 10 
site, impact, associated features and self-management of pain in a cross-sectional study of a 11 
population-based cohort of YP with bilateral CP.    12 
Methods 13 
Population The cohort is derived from a total population of children with bilateral cerebral 14 
palsy (CP) born 1989 to 1992 (inclusive) to mothers resident at the time of birth in a 15 
geographically defined area of south-east England (205,958 live births) who participated in a 16 
study of hip development in cerebral palsy; the Study of Hips and Physical Experience 17 
(SH&PE) 19,20.  As the original study focused on the development of hips uninfluenced by 18 
typical walking experience, the upper age limit for acquisition of CP was 15 months and 19 
children who died before 12 months of age were excluded. The cohort was examined at 2, 5 20 
years and 13-19 years. See flow chart. Figure 1. This paper provides a cross-sectional 21 
analysis of the teenage assessment. 22 
Measures 23 
Motor.  Functional motor ability was recorded using the Gross Motor Function Classification 24 
System (GMFCS I-V) (Palisano21) and separately as ambulant/non-ambulant (ambulant 25 
meaning any mobility using the legs with or without a walker/rollator etc). The passive range 26 
of movement was assessed using a goniometer. A total deformity score for the spine and 27 
lower limbs was calculated (see appendix). Type of motor disorder was recorded as 28 
predominantly spastic, dystonic, dyskinetic or other including ataxia. Current use of postural 29 
therapeutic equipment was recorded: standing frame, night lying support, spinal brace, hip 30 
abduction brace (total body), AFO and knee gaiters (limb) or none. 31 
Evaluation of Pain.  Presence and severity of pain was recorded on a visual Likert scale 32 
scored from 0 (none) to 10 (severe) pain over the preceding day, week and last 3 months; 33 
whether pain was regularly experienced and of what severity (mild/mod/severe), where 34 
(head, chest, back, arms, hips, legs, feet & tummy or other), (see appendix), when (at rest, 35 
when moving, when moved, when eating, daytime, at night or all the time), and when it was 36 
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worst. YP (and PCs) were asked about what treatment, if any, they used for pain (any 1 
analgesics used for regular pain were totalled for analysis purposes) and frequency of use 2 
(never/rarely; sometimes/quite often or a lot/all the time).   3 
Impact of Pain. The explicit impact of pain on daily life was reported by YP using the Brief 4 
Pain Inventory a 10 sub-section questionnaire of the impact of pain on recreational activity, 5 
school/college/work, mobility, self-care, sleep, mood and overall enjoyment, scored 0 (none) 6 
– 3 (a lot) with a total score of 0-30) 22.   7 
 8 
Quality of life was assessed using Kidscreen, a PC and YP reported 52 item questionnaire 9 
covering 10 dimensions (1-5 scale) physical health, psychological well-being in mood and 10 
emotions, self-perception, autonomy, home life, money matters, friends, school & learning 11 
and bullying in the last week23.  12 
 13 
General Health in the past 5 years was recorded in face to face interview with PCs and 14 
scored as 2 (definite), 1 occasional), 0 (none) for each of chest problems, epilepsy, 15 
gastrointestinal problems (including constipation) and ‘other’ (a mix of problems with shunts, 16 
urinary tract infection and other conditions but excluding orthopaedic procedures) giving a 17 
possible score of 8; in sub-analysis constipation was separately analysed.  18 
 19 
Neurodevelopment and Behaviour 20 
PCs reported communication and learning impairment as none, mild/moderate, severe. 21 
Speech was assessed directly by a research physiotherapist using the Pennington scale24 (a 22 
5 item scale from easily intelligible to no intelligibility and highly correlated with parental 23 
report of communication25). Children were categorised as having no Intellectual Disability-ID 24 
(0), mild/mod ID (1) or severe/profound ID (2) on the basis of the British Picture Vocabulary 25 
Scale (BPVS) score and additional school information. PCs completed the Strengths and 26 
Difficulties Questionnaire (SDQ)26. 27 
 28 
Statistical analyses were carried out using Stata 14 27.  PC report informed the main 29 
analysis for presence, severity and associated features of pain because some YP could 30 
not self-report. As main outcomes we analysed the number with reported pain and pain 31 
severity in three different time periods and the presence of regular pain of moderate and 32 
severe degree. Pain severity scores (from the 11-point Likert scales) for the last day, week 33 
and 3 months were treated as continuous variables and absence/presence of regular 34 
moderate-severe pain was treated as binary.  Factors considered as potentially being 35 
associated with the main outcomes included: severity of motor impairment, as measured 36 
by GMFCS level (continuous variable) or an indicator for ambulatory/non-ambulatory 37 
6 
 
(categorical); degree of joint deformity, as measured by deformity score (continuous); 1 
motor disorder type (categorical); use of postural modifying equipment (categorical); 2 
general health index (continuous) and separately constipation (categorical). Associations 3 
between these factors and PC report of pain were first explored in bivariate analyses.  4 
SDQ total score, SDQ emotional problems subscore, gender, ID, speech impairment 5 
maternal education were then explored as possible factors affecting reporting of pain. 6 
Factors associated with pain severity were explored using a series of linear regression with 7 
pain severity scores (for the last day, week and 3 months) as the dependent variable, and 8 
using logistic regression with the absence/presence of moderate-severe regular pain as 9 
the dependent variable. Any factors indicating an association with pain severity at the p<.1 10 
level were retained in a multivariate analysis which included GMFCS level as a co-variate 11 
to explore the significance of such factors over and above severity of CP. Logistic 12 
regression was also used to test whether the presence of pain at particular sites was 13 
associated with the above factors. A series of linear regressions examined the association 14 
between pain severity (entered as independent variable) and impact, as measured by the 15 
BPI (dependent variable), controlling for levels of GMFCS, ID and speech. (see 16 
supplementary table A) To examine the association between pain severity and quality of life, 17 
pairwise correlations were run between pain severity scores and K-10 domain t-scores, 18 
firstly within the PC data and then within the YP data. Concordance of reporting and level of 19 
agreement between PC and YP reports of pain and associated features, where both were 20 
available, were determined using intra-class correlation coefficients and Cohen’s Kappa for 21 
continuous (pain severity scores) and categorical measures (absence/presence of regular 22 
pain, absence/presence of pain at various sites) respectively. 23 
RESULTS PC pain questionnaires were completed for a total of 212 individuals, by 24 
mothers (n=185), fathers (n=17), foster carers (n=3), grandparents (n=2), sisters (n=2), carer 25 
(n=1), aunt (n=1) (respondent missing (n=1)).  The YP were aged 13 years 8 months to 19 26 
years 3 months (mean age = 16.7 years, SD 1.3) at the time.  A total of 153 YP completed 27 
the self-report questionnaires. In 8 self-reporting YP, PCs said that they did not feel they 28 
could adequately describe the pain experiences of their teenager with typical learning ability 29 
so preferred not to comment.  Both PC and YP questionnaires were completed for 145 YP.  30 
Rates of severe/profound ID were significantly higher in the group lacking YP reports and a 31 
higher proportion were non-verbal. Sample characteristics are presented in Table 1.  32 
Table 1 here  33 
Selective attrition in the whole cohort was previously estimated25 comparing those who were 34 
seen at mean age 16 years with those who were not. Using GMFCS at age 2 years and 35 
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excluding those who had died, participants and non-participants did not differ in terms of 1 
GMFCS levels (p = .86).  2 
Frequency and severity of PC reported pain 3 
Seventy percent of PCs reported pain occurring in the last three months, 59% within the last 4 
week and 50% within the last day. Regular episodes of pain were reported by 56% of PCs, 5 
in the majority of whom this was moderate/ severe (89% of those with regular pain, 50% of 6 
the total sample).  7 
Factors associated with PC reported pain  8 
Pain was reported increasingly frequently with increasing levels of motor impairment, as 9 
indicated by GMFCS level and non-ambulant versus ambulant as well as in those with 10 
poorer general health at each time-period (all p values <.05 for pain for each of these 11 
predictors).   12 
Table 2 presents frequencies of the various measures of pain occurrence by GMFCS level 13 
and for ambulant versus non-ambulant participants. PC report of pain (at any time-point) was 14 
not associated with level of deformity, intellectual disability, speech level or gender, SDQ 15 
score or maternal education (all p values > .07).   16 
Table 2 here 17 
Pain was associated with equipment use at each time period (all p values <.05), but this 18 
finding disappeared when level of motor impairment (GMFCS) was controlled for.   19 
Factors associated with severity of PC reported pain  20 
Results from the regression analyses are presented in Table 3. In the bivariate analyses, 21 
higher levels of GMFCS, equipment use, and general health problems were all associated 22 
with increased pain severity in the last day, week and 3 months (all p values<.05).  The 23 
same was found for regular moderate/severe pain.  The multivariate analyses produced 24 
significant regression equations for pain in the last day (F(8, 200) = 3.96, p<.001, R2=.14), 25 
last week (F(4, 204) = 5.02, p<.001, R2=.09), last 3 months (F(5, 192)=3.83, p=.003, 26 
R2=.09), and for regular moderate/severe pain (X2(6)=23.7, p<.001).  The association 27 
between pain severity and general health remained (all p values <.001), even when GMFCS 28 
level was controlled for. When the general health index was replaced by a separate variable 29 
for constipation, the latter was associated with increased pain severity for the last day 30 
(p=.02) and 3 months (p=.02). Motor disorder type (specifically spasticity) was associated 31 
with increased pain severity in the last day (p=.002).  PC report of moderate/severe regular 32 
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pain was associated with higher SDQ emotion scores (p=.02) and greater equipment use 1 
(p=.04).  2 
Table 3 here   3 
Location of pain. Table 4 presents frequencies of any pain reported by PCs at various sites 4 
in the last 3 months by GMFCS level. Pain in any of arm, back, hip, leg or chest was 5 
reported by 77% of PCs and 66% reported pain at multiple sites.  PCs reported higher rates 6 
of hip [X2 (1)=5.88, p<0.05] and abdominal pain [X2 (1)=12.8, p<0.001] in the non-ambulant 7 
group compared to the ambulant group.  8 
Table 4 here 9 
 A series of logistic regressions (see Supplementary Table B) tested whether pain at the 10 
various sites was associated with GMFCS level, deformity, general ill health (or specifically 11 
constipation) or gender.  Hip pain was associated with higher levels of GMFCS (p=0.024) 12 
and constipation (p=0.015); abdominal pain was associated with higher levels of GMFCS 13 
(p=0.001), female sex (p=0.005), general ill health (p=.001) and constipation (p<0.001); 14 
chest pain was also associated with general ill health (p=.003) and constipation (p=0.008).  15 
Convergence between PC and YP reports 16 
For the 145 participants where both PC and YP reports were completed, parents reported 17 
pain a little more frequently than the YP, although not significantly so: 46% of PCs versus 18 
42% of YP reported pain in the last day (one-sample proportion test, p = .42); 58% of PCs 19 
versus 50% of YP reported pain in the last week (p=.06); and 71% of PCs versus 63% of YP 20 
reported pain in the last 3 months (p = .05).  However, intraclass correlations indicated good 21 
agreement between PC and YP pain severity scores (0 - 10) for pain occurring in the last 22 
day [ICC=0.60 (95% C.I. 0.48-0.69), p<0.001], the last week [ICC=0.70 (95% C.I. 0.61-0.78), 23 
p<0.001], and the last three months [ICC=0.75 (95% C.I. 0.66-0.82), p<0.001]. Regular pain 24 
was reported by 48% of YP of which the majority (82% of those with regular pain, or 39% of 25 
the total) was moderate to severe. Agreement between PC and YP self-reports of moderate-26 
severe regular pain was good (k=0.69, 95% C.I. 0.56-0.79, p<0.0001).   YP self-reports with 27 
PC reports were only available for 11 non-verbal YP, but within these there was strong 28 
agreement between PC and YP reports of moderate to severe regular pain:  six individuals 29 
were reported by both PCs and the YP as experiencing moderate to severe regular pain, 30 
with just one YP reporting this level of pain when the PC did not (k =0.81, 95% C.I. 0.23-31 
0.95, p=0.003).  32 
Pain in any of arm, back, hip, leg or chest was reported by 71% of YP. Hip pain was 33 
associated with female sex (p=0.024); and abdominal pain associated with constipation 34 
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(p=0.020). Agreement between PCs and YP reports of pain at each site was fair to good 1 
(kappa values ranged 0.48-0.64, all p<0.0001).  Almost two thirds (63.4%) of PCs reported 2 
pain at multiple sites, as did a similar proportion (61.4%) of YP, with moderate agreement as 3 
to which individuals this applied to (k =0.52, 95% C.I. 0.34-0.64, p<0.0001). 4 
Timing of pain 5 
Parents and YP were asked when pain occurred and was worst. The most frequent 6 
response was during voluntary movement, both in PC reports (41%) and YP reports (67%) 7 
[X2 (1)=9.72, p<0.05)]. This was followed by when moved (25% in both PC and YP reports), 8 
and then during daytime rest (17% in both PC and YP reports).  Pain during voluntary 9 
movement was associated with lower GMFCS levels (as a continuous variable) [β= -0.44, 10 
SE=0.14, p=0.003]; pain when moved was associated with higher GMFCS levels [β=1.05, 11 
SE=0.24, p<0.0001]. PCs tended to report pain was worst at night more frequently than YP 12 
28% versus 7%, [X2(1)=3.44, p=0.06].  Pain “all the time” was reported by 11% of PCs and 13 
3% of YP (Fisher’s exact, p=0.12). Pain was reported when eating by 2 individuals. 14 
Medication and other interventions for pain 15 
112 (53%) PCs and 74 (48%) YP reported their use of analgesic, anti-spasticity and other 16 
medicines.  17 
Simple analgesics (e.g., paracetamol and ibuprofen) were used by 77% of responding YP – 18 
frequency = ‘often’ or ‘very often’. PCs reported use of simple analgesics in 88% of the YP – 19 
‘often’ or ‘very often’.  20 
Muscle relaxants were the next most frequently used agents that may impact on the 21 
pathophysiology of pain: Baclofen (14%), Diazepam (6%) and regular Botulinum Toxin A 22 
injections (11%) as well as anti-reflux medications (12%) and laxatives (14%).  23 
PCs reported a third of YP were on more than 2 medications that may impact on Pain. 3% of 24 
families regularly used alternative therapies such as Acupuncture, Osteopathy and 25 
Homeopathy. 26 
Quality of life for YP and the impact of pain  27 
The modified Brief Pain Inventory Scale was completed by 147 YP explicitly describing the 28 
impact of pain on general activity, recreational and social activity, relationships, 29 
school/college/work, mobility, self-care, sleep, mood and overall enjoyment of life. Mobility 30 
was the area most affected (28% “quite a lot/a great deal”), followed by mood (20%), general 31 
activity (17%) and recreational activity (16%).  Total impact scores were found to be 32 
significantly predicted by PC pain severity scores for the last day (β=1.67, SE=0.20, 33 
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p<0.001)  past week, (β=1.76, SE=0.17, p<0.001)and 3 months (β=1.37, SE=0.16, p<0.001); 1 
also for YP pain severity scores for the last day (β=.1.64, SE=.20, p<.001) past week 2 
(β=1.55, SE=0.15, p<0.001), and 3 months (β=1.46, SE=0.14, p<0.001). Levels of GMFCS, 3 
ID and speech were not associated with total impact scores (all p-values>0.2, see 4 
Supplementary Table A). 5 
The Kidscreen was completed by 187 PCs and 129 YP. Pain severity reported by PCs in the 6 
last week and in the last 3 months were negatively correlated with physical well-being 7 
domain t-scores [r (184)= -0.31, p<0.0001; r (183)= -0.36, p<0.001] and psychological well-8 
being t-scores [r (183)= -0.01, p=0.01]; [r(183)= -0.17, p=0.02]; and in the last 3 months, with 9 
mood and emotions t-scores [r (181)= -0.16, p=0.03], but no other domains. YP reports of 10 
pain severity in the last week and 3 months were negatively correlated with YP physical 11 
wellbeing t-scores [r(126)= -0.31, p<0.001]; [r(126 = -.40, p<0.001],  mood and emotions t-12 
scores [r(126)= -0.21, p=0.02)] and with psychological well-being t-scores [r(126)= -0.31, 13 
p<0.001] and autonomy t-scores [r(126)= -0.20, p=0.02] for pain in the last 3 months. 14 
Discussion 15 
Our study of surviving teenagers with bilateral cerebral palsy from a total population cohort 16 
confirms that pain is a common experience for these young people at an age when YP are 17 
striving for greater independence in the world28, and is associated with severity both of motor 18 
impairment (increasing GMFCS and non-ambulant) and general health but not deformity, 19 
gender, SDQ score, intellectual disability or maternal education (this is in line with previous 20 
cross sectional studies)3,4,6 . It is important to note that some YP in all GMFCS groups 21 
experience regular moderate/severe pain. 22 
A key finding from this study is that severity of general ill-health, independent of motor 23 
severity, is the factor most strongly associated with pain severity at all time periods and with 24 
regular moderate/severe pain. Gastrointestinal dysfunction in CP especially problems of 25 
motility, for which constipation is a marker, has received more attention in recent years but 26 
management remains a challenge. For many YP GI function remained a problem despite 27 
treatment. Spasticity was associated with greater pain severity in the last day and 28 
moderate/severe regular pain with the use of postural modifying equipment  and a higher 29 
SDQ emotional score, as found previously 4,14.  30 
Parent/carer and YP agreement both for pain presence and severity was high (Kappa of .69 31 
for moderate/severe regular pain, agreement previously reported as Spearman rank 0.45 3,4) 32 
and fair to good for site mainly arm, back, hip, leg or chest. Abdominal pain was more 33 
common in females. Two thirds reported multiple sites of pain.  34 
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Our prevalence of pain rates, 70% in the last three months, are similar to those reported in 1 
the SPARCLE study of similar age4, although that study included teenagers with unilateral 2 
as well as bilateral cerebral palsy. Reported rates of pain in a typical adolescent population 3 
are also high, 74% experiencing pain in any of headache, backache or stomach ache at 4 
least monthly in the last 6 months, more in females than males which differs from our 5 
study29. However, in our study 56% of YP experienced regular pain, moderate or severe in 6 
89%, despite significant medication use.  7 
Pain severity had a negative impact on quality of life assessed using the BPI which explicitly 8 
links pain to impact  and although the Kidscreen does not make a direct link to pain, the BPI 9 
and Kidscreen findings were very similar in measures of physical and psychological 10 
wellbeing. 11 
Pain in CP has previously been linked to physical interventions including those intended to 12 
be therapeutic4. We found that pain occurs at different times and with different activities in 13 
different GMFCS groups. Pain was reported in our non-ambulant group when being moved 14 
and in the ambulant group when actively mobile and in the chest/shoulders and arms of 15 
children using assistive mobility device. An important factor to be considered in clinical care 16 
is our finding that therapeutic postural modifying equipment independent of severity of motor 17 
impairment was associated with moderate/severe regular pain. An inability to move 18 
independently often means pain becomes more obvious at night but this was reported more 19 
by parents than YP and there was no correlation with perceived impact on quality of life and 20 
sleep from YP self-report. Of course, a potential confounder is that the most severely 21 
impaired group were less able to comment on their sleep quality. 22 
While self-report remains the gold standard when assessing pain, extrapolation from these 23 
findings allows reasonable confidence to be assumed for PC report as a proxy measure.  24 
Recognition is only half the battle. As stated by Blackman et al18, recognition of Pain is step 25 
one in our understanding of its underlying pathophysiology in YP with CP. In turn this may 26 
aid us in focussing on appropriate and potentially novel ways of pharmacological and 27 
therapeutic intervention to enable comfort and function.  28 
 29 
Summary, review and recommendations 30 
Increasing awareness of pain and the co-morbidities in CP, particularly general health and 31 
constipation, may help prevent and more effectively treat and thereby reduce the high levels 32 
of pain experienced by young people with cerebral palsy. In line with the recommendations 33 
12 
 
of the recent NICE guidelines it is imperative to consider the potential mechanisms and the 1 
physical and emotional manifestations of Pain in any YP with CP.  2 
 Pain is a common, significant experience in teenagers with bilateral Cerebral palsy 3 
 Appropriate recognition and management of pain is at the core of any individual’s 4 
clinical need.  5 
 Unless core Physical and Psychological comfort is optimised any positive impact of 6 
more complex multidisciplinary interventions to improve function in YP with CP can 7 
be compromised. 8 
 If the functional ability of any individual with CP regresses, then it is important to 9 
consider Pain as a potential root cause. 10 
 Before any new clinical medical or therapeutic intervention is considered, it is 11 
important to consider the potential impact that it may have on Pain in the Young 12 
person with CP. 13 
 As such it is vital that appropriate, evidence based Pain scores should be used as an 14 
integral part of regular reviews of YP with CP, in order to guide recognition and 15 
management by all individuals involved in their care.  16 
Strengths of study are a total geographically derived population cohort with bilateral 17 
Cerebral Palsy; both parent and teenager reports with measures of frequency, severity, site, 18 
time, impact and intervention for pain and a range of associated factors. 19 
Limitations of the study are that this is across sectional questionnaire study, there are 20 
small numbers in some YP self-reporting GMFCS sub-groups and incomplete reporting in 21 
questionnaires by a small number of YP.  22 
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Figure 1: Sample Ascertainment 11 
 12 
205,958 live births in 1989-1992 
South East Thames Regional Health 
Authority (SETHRA) 
All children alive at 12 months, with onset of 
motor problem before 15 months and mother 
resident in SETHRA, referred to the study 
n=537 Accepted onto 
study 
n=491 
Examined and not 
accepted onto study: 
46 with motor delay, not 
CP At age 2, examined 
and excluded: 
90 with hemiplegia 
diagnosis 
Reassessed at age 5, 
excluded:  
40 with motor delay, not CP 
5 with hemiplegia diagnosis 
(2 autism toe walkers) 
11 motor disorder not CP 
Eligible cohort retraced 2007-2008 
n=345 
 
Untracea
ble 
n=7  
 
Traced 
n=338 
Declined to participate 
n=27 (4 parents consented but YP refused) 1 
agreed notes could be used)  
No 
reply/unconta
ctable 
n=20 
Excluded due to 
progressive disorders 
n=2 Consented to be 
seen 
n=229 Young people seen for 
assessment, age 13-19 
n=220  Parent/carer questionnaires 
completed 
n=212 
Died by 
age 18 
n=60 
Self-report 
questionnaires 
completed 
N=145 
9  YP consented but 
not seen   
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Table 1.  Participant characteristics  1 
Characteristics PC data 
(N=212) 
PC and YP 
data (n=145) 
PC data only 
(n=67) 
Male (n (%)) 132 (62.3) 97 (66.9) 35 (52.2) 
Female (n (%)) 80 (37.7) 48 (33.1) 32 (47.8) 
    
Mean age (SD) 16.7 years (1.3) 16.8 (1.2) 16.6 (1.3) 
    
Gestational age (n (%)): 
>40 weeks (post term) 
37-40 weeks (term) 
32 – 36 weeks (mod preterm) 
28 – 31 weeks (very preterm) 
<28 weeks (extremely preterm) 
 
 
3 (1.4%) 
107 (50.5%) 
39 (18.4%) 
38 (17.9%) 
25 (11.8%) 
 
3 (2.1%) 
63 (43.5%)** 
27 (18.6%) 
32 (22.1%)* 
20 (13.8%) 
 
0 (0%) 
44 (65.7%)** 
12 (17.9%) 
6 (9.0%)* 
5 (7.5%) 
GMFCS I (n (%)) 27 (12.7) 26 (17.9)*** 1 (1.5)*** 
GMFCS II  (n (%) 58 (27.4) 50 (43.5)*** 8 (11.9)*** 
GMFCS III (n (%)) 27 (12.7) 25 (17.2)** 2 (3.0)** 
GMFCS IV (n (%)) 34 (16.0) 22 (15.2) 12 (17.9) 
GMFCS V (n (%)) 66 (31.1) 22 (15.2)*** 44 (67.7)*** 
    
Ambulant (n (%)) 133 (62.7) 111 (76.5) 22 (32.8) 
Non-ambulant (n (%)) 79 (37.3) 34 (23.5)*** 45 (67.2)*** 
    
Primary disorder, n=210:    
spastic (n (%) 164 (78.1) 113 (78.5) 51 (77.2) 
dystonic (n (%)) 18 (8.6) 11 (7.6) 7 (10.6) 
ataxia (n (%)) 11 (5.2) 9 (6.3) 2 (3.0) 
involuntary athetosis  (n (%)) 4 (1.9) 2 (1.4) 2 (3.0) 
other (n (%)) 13 (6.2) 9 (6.3) 4 (6.1) 
    
Constipation problems (n (%)) 75/210 (35.7) 45 (31.3)* 30 (45.5)* 
GI reflux/upper GI problems (n (%)) 26/211 (12.3) 10 (6.9)*** 16 (23.9)*** 
Mean health index (SD), n=211 1.78 (1.78) 1.37 
(1.57)*** 
2.64 (1.91)*** 
    
Mean lower limb deformity score 
(SD), n=183 
6.0 (4.15) 7.39 
(4.11)*** 
5.17 (3.33)*** 
    
Speech    
Normal/typical (n (%)) 77 (36.3) 73 (50.3)*** 4 (6.0)*** 
Mainly intelligible to unfamiliar (n 
(%)) 
49 (23.1) 42 (29.0)** 7 (10.5)** 
Mostly not intelligible to unfamiliar (n 
(%)) 
21 (9.9) 14 (9.7) 7 (10.5) 
Severe but mostly familiar to familiar 
(n (%)) 
8 (3.8) 5 (3.5) 3 (4.5) 
Open vowels only, unintelligible to all 
(n (%)) 
57 (26.8) 11 (7.6)*** 46 (68.7)*** 
    
Level of intellectual disability, n=211    
None (n (%)) 
Mild (n (%)) 
Moderate (n (%)) 
Severe (n (%)) 
45 (21.3) 
44 (20.9) 
44 (20.9) 
50 (23.7) 
45 (31.0)*** 
42 (29.0)*** 
36 (24.8)* 
19 (13.1)*** 
0 (-)*** 
2 (3.0)*** 
8. (12.1)* 
31 (47.0)*** 
18 
 
*Fisher’s Exact or X2, p<.05, **Fisher’s Exact, X2, p<.01, ***Fisher’s Exact, X2, or t-test 1 
p<.001 2 
3 
Profound (n (%)) 
 
28 (13.3) 3 (2.1) 25 (37.8)*** 
Ethnicity: White Caucasian (n (%)) 
 
174 (82.5) 119 (82.6) 55 (82.1) 
Maternal Education, n=201:  
No formal qualifications (n (%)) 
GCSEs (n (%)) 
A-levels (n (%)) 
City and Guilds (n (%)) 
Undergraduate degree (n (%)) 
Postgraduate degree (n (%)) 
 
38 (18.9) 
78 (38.8) 
24 (11.9) 
26 (12.9) 
29 (14.4) 
6 (3.0) 
 
26 (18.4) 
52 (36.9) 
19 (13.4) 
19 (13.5) 
20 (14.2) 
5 (3.6) 
 
 
12 (20.0) 
26 (43.3) 
5 (8.3) 
7 (11.7) 
9 (15.0) 
1 (1.7) 
    
Employment: at least one parent 
employed (n (%)) 
106/204 (52.0) 66 (46.2)* 46 (65.6)* 
    
N (%) reporting pain in time period:    
Last day 105 (50.4) 67 (46.2) 38 (56.7)  
Last week 126 (59.4 ) 84 (57.9) 42 (62.7) 
Last 3 months 149 (70.3) 103 (71.0) 46 (68.7) 
    
N (%) with moderate-severe regular 
pain 
106 (50.0) 70 (48.3) 36 (53.7) 
 
    
Equipment use:    
Prone-standing frame (n (%)) 17 (8.0) 4 (2.3%)** 13 (19.4)** 
Upright standing-frame (n (%)) 36 (17.0) 16 (11.0)** 20 (29.9)** 
Night lying support (n (%)) 35 (16.5) 16 (11.0)* 19 (28.4)* 
Spinal brace (n (%)) 11 (5.2) 1 (0.7)*** 10 (14.5%)*** 
Hip abduction brace (n (%)) 2 (0.9) - 2 (3.0) 
Ankle-foot-orthotics (n (%)) 45 (21.2) 28  (19.3) 17 (25.4) 
Knee gaiters (n (%)) 18 (8.5) 10 (6.9) 8 (11.9) 
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Table 2. Parent-reported pain frequency (%) by GMFCS level for pain experienced in last 1 
day, last week and last three months and regular mod/severe pain 2 
 3 
 GMFCS Level Test of 
trend p-
value 
 Chi-square p-
value 
 I II III IV V  Ambulant Non-ambulant  
Pain in last day 5 
(19.5%) 
27 
(46.6%) 
15 
(55.6%) 
18 
(52.9%) 
40 
(60.6%) 
.001 57 (42.9%) 48 (60.8%) .012 
Pain in last week  11 
(40.7%) 
33 
(56.9%) 
17 
(63.0%) 
21 
(61.8%) 
44 
(66.7%) 
.036 70 (52.6%) 56 (70.9%)  .009 
Pain in last 3 
months 
14 
(51.9%) 
38 
(65.5%) 
20 
(74.1%) 
25 
(73.5%) 
52 
(78.8%) 
.010 83 (62.4%) 66 (83.5%) .001 
Moderate/severe 
regular pain 
8 
(29.6%) 
26 
(44.8%) 
16 
(59.3%) 
19 
(55.9%) 
37 
(56.1%) 
.024 58 (43.6%) 48 (60.8%) .016 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
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Table 3: Regression coefficients for potential predictors of PC reports of pain severity, and 1 
moderate/ severe regular pain 2 
  Bivariate regression Multivariate regression 
Timescale Covariate Coefficient (SE)        p-value Coefficient (SE) p-value 
Pain in last day  
(0-10) 
Gender -.24 (.34) .49   
GMFCS level .28 (.11) .01 .09 (.17)              .60 
Motor type -1.8 (.59) .003 -1.97 (.59) .002 
Deformity score .05 (.04) .19   
Equipment use  .45 (.18) .01 .16 (.23) .49 
General health index .37 (.09) <.001 .32 (.10) .002  
Constipation 
SDQ total 
.1.25 (.34) 
        .08 (.05)            
<.001 
    .89 
.87 (.35) .02 
SDQ emotion .12 (.10) .22   
Intellectual disability .07 (.09) .42   
Speech scale .18 (.10) .09 -.03 (.15) .81 
 Maternal education .18 (.12) .13   
      
 Gender -.04 (.37) .92   
Pain in last week 
(0-10) 
GMFCS level .27 (.12) .03 -.07 (.16) .67 
Motor type -1.91 (.64) .003 -.17 (.11) .12 
Deformity score .02 (.05) .66   
Equipment use  .62 (.19) .002 .40 (.25) .12 
General health index .38 (.10) <.001 .30 (.11) .005 
Constipation .99 (.38) .009 .63 (.39) .12 
SDQ total .01 (.05) .83   
SDQ emotion .19 (.11) .38   
Intellectual disability .04 (.10) .69   
Speech scale .10 (.11) .38   
Maternal education .15 (.13) .25   
     
Gender -.05 (.42) .91   
Pain in last 3m  
(0-10) 
GMFCS level .36 (.14) .01 .14 (.18) .44 
Motor type -1.47 (.75) .05 -.01 (.13) .92 
Deformity score .04 (.05) .41   
Equipment use  .48 (.22) .03 .12 (.29) .68 
General health index .45 (.11) <.001 .34 (.12) .006 
Constipation 1.43 (.42) .001 1.07 (.44) .02 
SDQ total .06 (.06) .33   
SDQ emotion .18 (.12) .13   
Intellectual disability -.02 (.11) .81   
Speech scale .17 (.12) .16   
Maternal education .27 (.14) .07 .25 (.14) .08 
     
 Gender         .16 (.28)             .57   
Moderate/severe 
regular pain 
(absent/present) 
GMFCS level .22 (.10) .03 -.24 (.25) .33 
Motor type -.97 (.52) .07 -1.3 (1.04) .30 
Deformity score .06 (.04) .17   
Equipment use  .55(.16) <.001 .84 (.41) .04 
General health index .31 (.09) <.001 -.07 (.15) .63 
Constipation .51 (.29) .08 -.56 (.61) .35 
SDQ Total .07 (.05) .17   
SDQ emotion .21 (.10) .03 .32 (.13) .02 
Intellectual disability .10 (.08) .21   
Speech scale .13 (.09) .12   
Maternal education .23 (.10) .03 -1.31 (1.27) .30 
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 1 
Table 4. Frequencies (%) of PC reports of pain by site and GMFCS, and PC-YP 2 
agreement on reports of pain at each site 3 
 GMFCS level Test of 
trend p-
value 
PC-YP 
agreement  
on site of pain 
(k (95% CI)) 
 I II III IV V   
 n=27 n=58 n=27 n=34 n=66   
Leg 15 
(55.6%) 
33 
(56.9%) 
19 
(70.4%) 
18 
(52.9%) 
31 
(48.0%) 
.272 .60 (.45-.71), 
p<.0001 
Hip 7 
(25.9%) 
15 
(25.9%) 
17 
(63.0%) 
18 
(52.9%) 
33 
(50.0%) 
.002 .55 (.40-.68), 
p<.0001 
Back 8 
(9.5%) 
22 
(26.2%) 
12 
(44.4%) 
10 
(29.4%) 
32 
(49.2%) 
.140 .59 (.44-.70), 
p<.0001 
Abdomen 6 
(22.2%) 
16 
(27.6%) 
11 
(40.7%) 
18 
(52.9%) 
40 
(60.6%) 
<.001 .51 (.35-.64), 
p<.0001 
Chest 4 
(14.3%) 
4 
(6.9%) 
5 
(18.5%) 
2 
(5.9%) 
13 
(20.0%) 
.206 .48 (.27-.65), 
p<.0001 
Head 10 
(27.0%) 
17 
(29.3%) 
8 
(29.6%) 
6 
(17.7%) 
24 
(36.9%) 
.920 .55 (.39-.68), 
p<.0001 
Arm 6 
(22.2%) 
14 
(24.1%) 
8 
(29.6%) 
5 
(14.7%) 
19 
(29.2%) 
.647 .64 (.47-.76), 
p<.0001 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
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Supplementary Table A.  Regression coefficients for predictors of total impact score from the Brief Pain 1 
Inventory  2 
 Covariate Coefficient (SE) p-value 
Total impact Pain in the last day (PC report) 1.67 (.17) <.001 
 GMFCS level .06 (.42) .880 
 Speech scale .02 (.49) .98 
 Intellectual disability -.56 (.44) .20 
    
 Pain in the last week (PC report) 1.76 (.17) <.001 
 GMFCS level .09 (38) .80 
 Speech scale .21 (.45) .65 
 Intellectual disability -.54 (.40) .18 
    
 Pain in the last 3 months (PC report) 1.37 (.16) <.001 
 GMFCS level -.10 (.42) .81 
 Speech scale -.24 (.48) .63 
 Intellectual disability -.54 (.44) .22 
    
Total impact Pain in the last day (YP report) 1.64 (.20) <.001 
 GMFCS level .12 (.41) .77 
 Speech scale -.12 (.48) .80 
 Intellectual disability -.30 .49 
    
 Pain in the last week (YP report) 1.54 (.15) <.001 
 GMFCS level .04 (.38) .92 
 Speech scale .10 (.33) .83 
 Intellectual disability -.42 (.40) .29 
    
 Pain in the last 3 months (YP report) 1.46 (.14) <.001 
 GMFCS level .16 (.37) .68 
 Speech scale -.60 (.43) .17 
 Intellectual disability -.26 (.39) .50 
 3 
4 
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 1 
Supplementary Table B.  Regressions coefficients for potential predictors of pain at various sites 2 
 Covariate Coefficient (SE) p-value 
Leg pain GMFCS level -.21 (.15) .14 
 Deformity score .02 (.05) .74 
 General health index .09 (.09) .34 
 Constipation .17 (.33) .62 
 Gender .37 (.32) .26 
    
Hip pain GMFCS level .54 (.15) .02 
 Deformity score .05 (.05) .31 
 General health index .14 (.09) .14 
 Constipation .91 (.35) .02 
 Gender .63 (.32) .05 
    
Back pain GMFCS level .06 (.15) .71 
 Deformity score -.001 (.05) .98 
 General health index .09 (.09) .28 
 Constipation .67 (.34) .06 
 Gender .24 (.32) .46 
    
Abdominal pain GMFCS level .21 (.16) .001 
 Deformity score .04 (.06) .45 
 General health index .38 (.10) .001 
 Constipation 1.53 (.37) <.001 
 Gender 1.05 (.35) .005 
    
Chest pain GMFCS level -.02 (.23) .90 
 Deformity score -.02 (.09) .85 
 General health index .38 (.13) .003 
 Constipation 1.14 (.49) .01 
 Gender .34 (.49) .49 
    
Pain in the Head  GMFCS level .65 (.16) .68 
 Deformity score -.12 (.07) .09 
 General health index .24 (.10) .13 
 Constipation .74 (.35) .36 
 Gender .17 (.34) .62 
    
Arm pain GMFCS level -.19 (.17) .29 
 Deformity score .06 (.06) .33 
 General health index .13 (.10) .10 
 Constipation .55 (.38) .15 
 Gender .60 (.37) .12 
 3 
 4 
 5 
 6 
 7 
 8 
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Pain Questionnaire SH&PE 1 
 (parent report) 2 
      Please put a point on the line that fits best with your child’s pain. 3 
 4 
1. Over the past day… Have they experienced any pain? 5 
 6 
0 10 7 
No pain        1         2        3         4         5         6          7          8          9    Pain as bad  8 
    as it could be 9 
 10 
2. Over the last week… Have they experienced any pain? 11 
 12 
0 10 13 
No pain        1         2        3         4         5         6          7          8          9    Pain as bad  14 
    as it could be 15 
 16 
3. Over the last three months… Have they experienced any pain? 17 
 18 
0 10 19 
No pain        1         2        3         4         5         6          7          8          9   Pain as bad  20 
   as it could be 21 
4. In which place (s) does your child get pain? (Please circle the best answer) 22 
 23 
Place   Not at all    A little Quite often All the time 
Legs Left        0        1        2        3 
 Right        0        1        2        3 
Hips Left        0        1        2        3 
 Right        0        1        2        3        
Back         0        1        2        3 
Tummy         0        1        2          3 
Chest         0        1        2        3 
25 
 
Head         0        1        2        3 
Arms Left        0        1        2        3 
 Right        0        1        2           3 
Other 
(Please specify) 
        0          1        2        3 
Other 
(Please specify) 
        0        1        2        3 
 1 
                                                                                         2 
5.   Does your child experience pain regularly?          Yes         No                                                                                                                          3 
 4 
6. Please circle the word that best describes the severity of this regular pain. 5 
 6 
1Mild          2Moderate    3Severe  7 
 8 
7. If they do experience pain regularly, when is that? (Please mark one or more if applicable) 9 
 10 
1 In the daytime at rest    4 At night-time     11 
                       12 
2 In the day-time with voluntary movement  5 All the time    13 
 14 
3 When someone moves them          6 When eating or talking   15 
 16 
7 Other   17 
 18 
 19 
Which time is worst?    ……………………………………… 20 
21 
26 
 
Appendix 1 
Deformity Index   2 
The passive range of each joint was assessed using a goniometer. This was performed in the supine 3 
position for the lower limb. To detect flexion contractures, the pelvis was stabilised and the 4 
contralateral hip was flexed to end range and the angle between the surface the participant was 5 
lying on and the thigh was measured. Hip rotation measures were taken with the hip and knee 6 
flexed to 90º where possible. In instances where there was a restriction to either hip or knee flexion, 7 
the lower limb joints were flexed to just short of full available flexion and rotation assessed in this 8 
position. Varus and valgus foot deformity and hallux valgus were noted and calculated as present or 9 
absent.  10 
An index of deformity was developed based on that used by Ostensjo 2004. Each joint range of 11 
movement was scored as 0 or 1 based on whether the range fell more than 2 SD outside the normal. 12 
The lower limb ranges were based on normal range identified from a group of 14 normally 13 
developing adolescents assessed in this hospital (age 13-22 mean 16.6yrs, 7 females 7 males). The 14 
sum of index components on each side of the body can reach a maximum of 14. Scores for both 15 
sides of the body are summed and added to this scale is a spinal score. It is difficult to calculate a 16 
measure for the spine from clinical assessment, so the following scoring from clinical findings was 17 
developed: a YP may have both sagittal plane and coronal plane changes. It was hypothesised that 18 
surgical fixation of the spine was a different but still significant change in body ROM and so was 19 
scored as noted.   20 
REF Ostensjo 2004 21 
Spine: 22 
0 = Neutral 23 
1 = Sagittal plane changes 24 
1 = Coronal plane changes 25 
1 = Surgical correction 26 
1 = Fixed pelvic obliquity in sitting 27 
 28 
Lower limb 29 
Score 1 2 3  1SD 2SD 3SD 
Hip flexion <120 <100 <90 Score 1 2 3 
Hip extension <0 <-20 >-20 Hip flexion <120 <100 <90 
Hip abduction 
(flexion)   
<45  
>70   
<30  
>80 
<20  
>95 
Hip extension <0 <-20 >-20 
Hip internal <35  <25   <15  Hip abduction <43  <30  <17  
27 
 
rotation >55 >65 >75 (flexion)   >69   >81 >94 
Hip external 
rotation 
<35  
>60 
<25  
>75 
<10  
>85 
Hip internal 
rotation 
<35  
>54 
<26   
>64 
<16  
>74 
Knee 
extension 
>1 FFD  
> 5 hyper 
>5 FFD 
> 10  
hyper 
>10  FFD 
>15  
hyper 
Hip external 
rotation 
<35  
>61 
<24  
>73 
<11  
>86 
Popliteal 
angle 
>60 > 70 >80 Knee 
extension 
>1 FFD  
> 5 hyper 
>5 FFD 
> 10  
hyper 
>10  FFD 
>15  hyper 
Ankle 
dorsiflexion 
<10DF 
> 20DF 
<0º DF 
>25 DF  
>5PF 
>30 DF  
Popliteal 
angle 
>60 > 70 >77 
    Ankle 
dorsiflexion 
> 20DF 
<9DF   
>25.5 DF   
<3º DF 
>31DF   
>2PF 
 1 
Valgus/varus  foot  deformity  no=0, mild =1, significant=2 2 
